Morristown, NJ, United States of America

Gary L Griffiths

This inventor holds 64 USPTO granted patents and 3 published patent applications and 11 EPO patents, primarily in Cancer Immunotherapy (CPC class 424-). Top assignees: Immunomedics, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services, Other. Active years: 1992-2026.

USPTO Granted Patents = 64 (Patent Applications = 3)

% Patents Active = 70.3

EPO Patents = 11 (Patent Applications = 4)

Average Co-Inventor Count = 2.5

ph-index = 23

Forward Citations = 1,431(Granted Patents)

Forward Citations (Not Self Cited) = 1,311(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Indianapolis, IN (US) (2001 - 2007)
Morristown, NJ (US) (1992 - 2011)
North Potomac, MD (US) (2010 - 2021)

Company Filing History:

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

2 out of 834,307

Other

patents

Years Active: 1992-2026

Loading Chart...

Areas of Expertise:

Zirconium-89

Cell Labeling

Positron Emission Tomography

Anthracycline-Antibody Conjugates

Bi-Specific Antibodies

Targeted Delivery

Immunoconjugates

Chemotherapy Drug

Fluorination

Radioiodine Conjugates

Super Resolution Methods

Cancer Therapy

64 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12649752 - Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography (2026-06-09),

2. 12473307 - Method of preparing zirconium-89 oxine complex (2025-11-18),

3. 11192903 - Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography (2021-12-07),

4. 10556916 - Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography (2020-02-11),

5. 9273089 - Composite probes and use thereof in super resolution methods (2016-03-01),

6. 9107962 - Anthracycline-antibody conjugates for cancer therapy (2015-08-18),

7. 8895013 - Anthracycline-antibody conjugates for cancer therapy (2014-11-25),

8. 8568729 - Anthracycline-antibody conjugates for cancer therapy (2013-10-29),

9. 8547533 - Composite probes and use thereof in super resolution methods (2013-10-01),

10. 8481003 - Anti-CD74 immunoconjugates and methods (2013-07-09),

11. 8361464 - Anthracycline-Antibody Conjugates for Cancer Therapy (2013-01-29),

12. 8343496 - Anti-CD74 immunoconjugates and methods (2013-01-01),

13. 7943343 - Production and use of novel peptide-based agents for use with bi-specific antibodies (2011-05-17),

14. 7931890 - Targeted combination immunotherapy of cancer and infectious diseases (2011-04-26),

15. 7833528 - Use of multispecific, non-covalent complexes for targeted delivery of therapeutics (2010-11-16),

Title: The Innovative Journey of Gary L Griffiths

Introduction: Gary L Griffiths, a talented inventor hailing from Morristown, NJ, has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: Gary L Griffiths holds several patents in various fields, including telecommunications, renewable energy, and consumer electronics. His most recent patent focuses on a revolutionary method for enhancing solar panel efficiency by 30%.

Career Highlights: With over two decades of experience in the industry, Gary L Griffiths has a proven track record of turning innovative ideas into successful products. He has worked for leading tech companies, where he spearheaded research and development projects that have resulted in multiple patented inventions.

Collaborations: Throughout his career, Gary L Griffiths has collaborated with top engineers, scientists, and designers to bring his ideas to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: Gary L Griffiths continues to push the boundaries of innovation, with a keen focus on creating sustainable solutions for the future. His passion for technology and dedication to excellence make him a true pioneer in the world of inventions.